Adaptimmune to present T cells clinical trial results Pharmaceutical Business Review The study also included patients who have received prior treatment for myeloma or who have disease considered to be high risk, and who are eligible for an autologous stem cell transplant. The clinical study chair Aaron Rapoport said, "From a clinical ... |
